Donor epstein-barr serostatus influences GVHD after allo-HSCT
(HealthDay)—Donor Epstein-Barr virus (EBV) serostatus influences incidence of graft-versus-host disease (GVHD) in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT), according ...
Apr 19, 2016
0
0